Henshaw Capital’s Labcorp LH Stock Holding History

Henshaw Capital’s Portfolio LH Stock Details LH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-3,459	Closed	-$458K	–	293
2017 Q2	$458K	Hold	3,459	–	–	0.05%	147
2017 Q1	$426K	Hold	3,459	–	–	0.05%	155
2016 Q4	$382K	Hold	3,459	–	–	0.05%	168
2016 Q3	$409K	Hold	3,459	–	–	0.05%	145
2016 Q2	$387K	Hold	3,459	–	–	0.05%	142
2016 Q1	$348K	Buy	+3,459	New	+$332K	0.05%	161

Other funds holding LH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

GCM

Glenview Capital Management New York $5.49B AUM 46.89% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

IAM

Iridian Asset Management Westport, Connecticut $291M AUM 49.45% 1-Year Est. Return

HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return

Henshaw Capital's LH Position: Q3 2017 in Review

Henshaw Capital sold out of Labcorp (LH) in Q3 2017, closing a stake of 3,459 shares — an estimated $458K sold.

Henshaw Capital first reported a position in LH in Q1 2016 and held it in 6 quarters. The position peaked at $458K in Q2 2017. 701 funds tracked by Wall St. Rank hold LH as of Q3 2017.

Henshaw Capital reported no remaining Labcorp position as of Q3 2017 after selling out during the quarter.
Henshaw Capital sold 3,459 Labcorp shares in Q3 2017, an estimated $458K.
Henshaw Capital first reported a position in Labcorp in Q1 2016 and held it in 6 quarters.
Henshaw Capital's Labcorp position peaked at $458K in Q2 2017.
701 funds tracked by Wall St. Rank held Labcorp as of Q3 2017.

Based on Henshaw Capital's 13F filing for Q3 2017, filed 28 May 2026.